Royalty Pharma plc (FRA:RPD)

Royalty Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,755	10,948	11,306	16,312	15,050	15,881
Market Cap Growth	36.74%	-3.17%	-30.69%	8.38%	-5.23%	-
Enterprise Value	24,398	20,604	19,119	25,576	23,466	23,224
Last Close Price	34.19	23.77	23.66	33.29	32.56	-
PE Ratio	22.63	13.20	11.01	407.00	27.62	39.23
PS Ratio	7.37	5.01	5.31	7.79	7.48	9.15
PB Ratio	1.80	1.10	1.24	1.83	1.67	1.96
P/TBV Ratio	3.16	1.63	1.92	3.11	2.97	4.06
P/OCF Ratio	7.20	4.09	4.18	8.13	8.48	9.55
EV/Sales Ratio	12.08	9.42	8.98	12.22	11.66	13.39
EV/EBITDA Ratio	-	-	14.11	29.44	18.36	16.88
EV/EBIT Ratio	17.53	16.51	14.16	29.62	18.65	17.11
Debt / Equity Ratio	0.93	0.74	0.61	0.75	0.69	0.59
Debt / EBITDA Ratio	-	-	4.10	7.66	4.88	3.46
Asset Turnover	0.13	0.13	0.14	0.13	0.14	0.15
Quick Ratio	3.47	1.43	7.78	2.11	16.77	8.73
Current Ratio	3.48	1.44	7.90	2.19	16.81	8.76
Return on Equity (ROE)	13.11%	13.03%	17.34%	2.33%	12.32%	21.22%
Return on Assets (ROA)	5.22%	4.67%	5.62%	3.36%	5.33%	7.29%
Return on Capital (ROIC)	5.36%	4.73%	5.68%	3.39%	5.41%	7.38%
Return on Capital Employed (ROCE)	8.30%	7.60%	9.20%	5.90%	8.20%	10.60%
Earnings Yield	4.42%	7.58%	9.08%	0.25%	3.62%	5.02%
Dividend Yield	2.27%	3.41%	3.06%	2.14%	1.84%	-
Payout Ratio	49.36%	43.83%	31.57%	778.21%	46.02%	40.80%
Buyback Yield / Dilution	3.98%	1.46%	-37.66%	-5.59%	-10.48%	-
Total Shareholder Return	6.25%	4.87%	-34.60%	-3.45%	-8.64%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.